For questions regarding pricing, throughput, and machine specifications please submit a technical sales inquiry. For all investor-related questions, please submit an investor-related inquiry below.
EnWave Corporation Selected as a 2019 Venture 50™ Company in the Clean Technology & Life Sciences Category and Announces Date of First Quarter 2019 Financial Results
Feb 21th 2019, 06:00am
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) a global leader in vacuum microwave dehydration technology, announced today that it has been selected as a 2019 Venture 50™ company in the Clean Technology & Life Sciences category.
The Venture 50 are the top ten companies listed on TSX Venture Exchange in each of five major industry sectors – mining, energy & energy services, clean technology & life sciences, diversified industries and technology – based on a ranking formula with equal weighting given to market cap growth, trading volume amount and share price appreciation. All data was ranked as of December 31, 2018.
EnWave made significant developments in its business during 2018, including substantial growth in its wholly owned subsidiary, NutraDried Food Company, with its Moon Cheese® snack product. The company also deployed its Radiant Energy Vacuum (“REVTM”) technology into the cannabis market, providing producers with a scalable technology solution for the rapid dehydration of cannabis plant material.
EnWave’s technology is especially attractive to producers and food processors looking to manufacture clean label and healthy snacks, as well as all natural food ingredients. EnWave continues to execute on its strategy to deploy royalty-bearing machinery in food, pharmaceutical and legal cannabis markets. The Company’s mission is to create a massive, non-correlated portfolio of royalty streams off a wide range of products in multiple verticals.
More information regarding EnWave Corporation, the 2019 Venture 50TM and a video overview of the company can be found at tsxventure50.com.
EnWave to Announce First Quarter 2019 Financial Results on February 28, 2019:
The Company also announced today it will report its financial results for the first quarter of fiscal year 2019 on Thursday, February 28, 2019 prior to market open.
EnWave Corporation, a Vancouver-based advanced technology company, has developed Radiant Energy Vacuum (“REV™”) – an innovative, proprietary method for the precise dehydration of organic materials. EnWave has further developed patent-pending methods for uniformly drying and decontaminating cannabis through the use of REV™ technology, shortening the time from harvest to marketable cannabis products.
REV™ technology’s commercial viability has been demonstrated and is growing rapidly across several market verticals in the food, and pharmaceutical sectors including legal cannabis. EnWave’s strategy is to sign royalty-bearing commercial licenses with industry leaders in multiple verticals for the use of REV™ technology. The company has signed over twenty royalty-bearing licenses to date, opening up nine distinct market sectors for commercialization of new and innovative products. In addition to these licenses, EnWave has formed a Limited Liability Corporation, NutraDried Food Company, LLC, to develop, manufacture, market and sell all-natural cheese snack products in the United States under the Moon Cheese® brand.
EnWave has introduced REV™ as the new dehydration standard in the food and biological material sectors: faster and cheaper than freeze drying, with better end product quality than air drying or spray drying. EnWave currently has three commercial REV™ platforms:
- nutraREV® which is used in the food industry to dry food products quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour;
- powderREV® which is used for the bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes below the freezing point, and
- quantaREV® which is used for continuous, high-volume low-temperature drying.
An additional platform, freezeREV®, is being developed as a new method to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.
Mr. Brent Charleton
President and CEO
For further information:
John P.A. Budreski, Executive Chairman at
+1 (416) 930-0914
Brent Charleton, CFA , President and CEO
at +1 (778) 378-9616
Deborah Honig, Corporate Development
at + 1 (647) 203-8793
Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management’s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company’s strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third party claims referred to in this release are not guaranteed to be accurate. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.